SOUTH SAN FRANCISCO, Calif., Oct. 24 /PRNewswire-FirstCall/ -- Anesiva, Inc. will announce financial results for the third quarter 2007 after the markets close on Thursday, November 1, 2007 and will hold a webcast teleconference at 4:30 p.m. EDT that day. Members of Anesiva’s management team will discuss financial results from the third quarter 2007 as well as provide an overview of the company’s product pipeline, recent events and milestones.
Interested parties can listen to the live audio webcast by dialing 877-886-3540 (international dial: 706-643-9304) or by logging on to http://www.anesiva.com and going to the Investor Information page. For those unable to participate via the Internet, a 24-hour replay will be available for seven days after the call by dialing 800-642-1687 (international dial: 706-645-9291) and giving the following pass code: 21417682. The webcast will be available until the company’s next quarterly financial results conference call.
About Anesiva and its Diverse Pipeline of Pain Products
Anesiva, Inc. is a late-stage biopharmaceutical company that seeks to be the leader in the development and commercialization of novel therapeutic treatments for pain. The company has one FDA-approved product, Zingo(TM) (lidocaine hydrochloride monohydrate) powder intradermal injection system, to reduce pain associated with peripheral venous access procedures in children three to 18 years of age. The second product in Anesiva’s pipeline, Adlea(TM) (formerly 4975), has been shown to reduce pain after only a single administration for weeks to months in multiple settings in numerous mid-stage clinical trials for site-specific, moderate-to-severe pain. Anesiva is based in South San Francisco, CA. For more information about Anesiva’s leadership in the development of products for pain management, and an overview of the clinical challenges being addressed by its product candidates, go to http://www.anesiva.com.
CONTACT: Paul Goodson, Senior Director, Investor Relations of Anesiva,
Inc. +1-650-246-6898, investors@anesiva.com
Web site: http://www.anesiva.com/
